An ethics complaint leads to a resignation, and the agency shifts approval standards.

The government isn’t the only arbiter of product quality.

The U.S. Food and Drug Administration said on Thursday it has awarded six more companies, including Eli Lilly and Novo ...

Eli Lilly expects the U.S. Food and Drug Administration to approve its experimental oral obesity drug, orforglipron, by March ...

() -​Rhythm Pharmaceuticals ‌said on Friday ‌the U. Food and ⁠Drug ‌Administration has extended the ‍review period for ...

The FDA has approved daratumumab and hyaluronidase (DARA SC; Darzalex Faspro, Janssen Biotech) for adults with high-risk smoldering multiple myeloma (SMM). The approval makes DARA SC, a subcutaneous ...

The expanded indication for the oral atypical antipsychotic now includes adjunctive use with antidepressants in adults with major depressive disorder.

For the first time, patients with abnormal cells detected in their bone marrow have a treatment option before the condition ...

Q3 2025 Earnings Call Transcript November 6, 2025 Viatris Inc. beats earnings expectations. Reported EPS is $0.67, ...

Eli Lilly’s star oral GLP-1 candidate orforglipron and Novo Nordisk’s Wegovy (semaglutide) were named voucher winners in a ...

The FDA has updated the label indication for linaclotide capsules for the treatment of irritable bowel syndrome with ...

U.S. health regulators sent warning letters to 18 websites selling counterfeit or unapproved versions of Botox and similar ...